Completed NA INTERVENTIONAL 1-arm NCT02624271

Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk (GASTRO-PRA)

Non Invasive Diagnosis of Gastric Precancerous Lesions by GastroPanel Blood Test in Patients With Increased Gastric Cancer Risk : a French Multicenter Study

Sponsor: Nantes University Hospital

Conditions Gastric Cancer Gastric Precancerous Lesions

Interventions blood samples analysis

Updated 6 times since 2017 Last updated: Nov 13, 2023 Started: Aug 4, 2016 Primary completion: May 9, 2019 Completion: May 9, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Gastric Cancer and Gastric Precancerous Lesions and is currently completed. Nantes University Hospital leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2023 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Dec 2023 [monthly]

Unknown Status NA
May 2018 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2018 [monthly]

Not Yet Recruiting NA

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nantes University Hospital

Data source: Nantes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nantes, France